Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Tetra Pharm Technologies and Kvantify Join Forces to Speed Up Discovery of Novel Drug Candidates Focusing on the Endocannabinoid System

Friday, May 31, 2024

Tetra Pharm Technologies and Kvantify have formed a strategic partnership to accelerate the discovery and development of drug candidates targeting the endocannabinoid system

Coriolis Pharma Announces Launch of U.S. Entity, Offering Innovative Services for Monoclonal Antibodies

Thursday, May 30, 2024

Coriolis Pharma a prominent player in RD and GMP drug product development analytics and sterile drug manufacturing support has announced the establishment of its US entity This move signifies

Bluejay Therapeutics Receives Positive Opinion on Orphan Designation from European Medicines Agency for BJT-778 Targeting Chronic Hepatitis D

Thursday, May 30, 2024

Bluejay Therapeutics a clinicalstage biopharmaceutical company focused on addressing viral and liver diseases with unmet medical needs has received positive news from the European Medicines Agency

Nanite and SalioGen Therapeutics Collaborate on Non-Viral Nanoparticle for Cystic Fibrosis Gene Therapy Targeting Lungs

Thursday, May 30, 2024

Nanite Inc and SalioGen Therapeutics have recently entered into a collaborative research venture aimed at utilizing Nanites SAYER delivery platform The goal is to develop a lungtargeting

Menten AI Concludes Successful Research Partnership with Bristol Myers Squibb

Wednesday, May 29, 2024

Menten AI Inc a biotech company specializing in peptide macrocycle design and optimization through AI has announced the completion of a collaborative research venture with Bristol Myers Squibb

Cartography Enters Strategic Collaboration with Gilead to Develop Oncology Treatments Targeting New and Combined Targets

Wednesday, May 29, 2024

Cartography Biosciences Inc has unveiled a new strategic collaboration with Gilead Sciences Inc aimed at developing therapies for patients with triplenegative breast cancer

Evotec and CHDI Foundation Extend Strategic Partnership for Huntington’s Disease Drug Discovery

Wednesday, May 29, 2024

Evotec SE has recently announced the extension of its collaboration with CHDI Foundation Inc CHDI a nonprofit organization dedicated to advancing therapies for Huntingtons disease aims to significantly

Unravel Biosciences Secures FDA Orphan Drug Designation for Vorinostat (RVL-001) in Rett Syndrome Treatment

Wednesday, May 29, 2024

Unravel Biosciences Inc has just received Orphan Drug Designation from the United States Food and Drug Administration for vorinostat as a potential treatment for Rett Syndrome

Helsinn and Angelini Pharma Extend Partnership to Market AULIN® and MESULID® in Bulgaria, Czech Republic, Hungary, Poland, Romania, and Slovak Republic

Tuesday, May 28, 2024

Helsinn Group a prominent pharmaceutical company specializing in supportive care oncology and

Tyligand Bioscience Initiates Phase 1/2 Clinical Trial for TSN1611, a Selective Oral KRAS G12D Inhibitor, with First Patient Dosed

Monday, May 27, 2024

Tyligand Bioscience a prominent biotechnology company focused on developing cuttingedge cancer therapies has reached a significant milestone with the initiation of the Phase trial of TSN